Review article: oesophago-gastric adenocarcinoma -- an epidemiological perspective
- PMID: 15456465
- DOI: 10.1111/j.1365-2036.2004.02133.x
Review article: oesophago-gastric adenocarcinoma -- an epidemiological perspective
Abstract
This article reviews the epidemiology of cancers arising in the distal oesophagus and proximal stomach, sometimes collectively termed oesophago-gastric junctional adenocarcinomas. The several complexities involved in defining this group of cancers are considered and the reported increasing trends in incidence are reviewed, together with the descriptive epidemiology. The rates of these cancers are increasing, but not as dramatically as sometimes reported. They are also more common in white males than in other ethnic groups or in females. Although several aetiological risk factors have been reported, the two most consistent are an elevated body mass index (obesity) and a history of gastro-oesophageal reflux disease. Reflux is also associated with Barrett's oesophagus, an important and increasingly diagnosed premalignant lesion. The rate of progression from Barrett's oesophagus to cancer is controversial, as is the cost-benefit balance of routine endoscopic surveillance of such patients. The development of molecular biomarkers to identify Barrett's oesophagus patients with high rates of malignant transformation would represent a significant advance.
Similar articles
-
Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.Cancer. 2003 Sep 1;98(5):940-8. doi: 10.1002/cncr.11568. Cancer. 2003. PMID: 12942560
-
Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?Gut. 2005 Mar;54 Suppl 1(Suppl 1):i1-5. doi: 10.1136/gut.2004.041517. Gut. 2005. PMID: 15711002 Free PMC article. Review.
-
Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?Endoscopy. 2006 Feb;38(2):162-9. doi: 10.1055/s-2005-921184. Endoscopy. 2006. PMID: 16479424
-
Review article: Barrett's oesophagus and carcinoma in Japan.Aliment Pharmacol Ther. 2004 Dec;20 Suppl 8:50-4. doi: 10.1111/j.1365-2036.2004.02230.x. Aliment Pharmacol Ther. 2004. PMID: 15575874 Review.
-
Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland.Br J Cancer. 2000 Aug;83(3):387-90. doi: 10.1054/bjoc.2000.1110. Br J Cancer. 2000. PMID: 10917556 Free PMC article.
Cited by
-
Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.Curr Oncol. 2006 Feb;13(1):33-43. doi: 10.3747/co.v13i1.76. Curr Oncol. 2006. PMID: 17576439 Free PMC article.
-
Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction.World J Surg. 2010 Dec;34(12):2821-9. doi: 10.1007/s00268-010-0783-y. World J Surg. 2010. PMID: 20827475
-
The role of cancer registries in cancer control.Int J Clin Oncol. 2008 Apr;13(2):102-11. doi: 10.1007/s10147-008-0762-6. Epub 2008 May 8. Int J Clin Oncol. 2008. PMID: 18463952 Review.
-
Clinicopathological Characteristics and Prognosis of Upper Gastric Cancer Patients in China: A 32-Year Single-Center Retrospective Clinical Study.Gastroenterol Res Pract. 2019 Dec 1;2019:9248394. doi: 10.1155/2019/9248394. eCollection 2019. Gastroenterol Res Pract. 2019. PMID: 31885548 Free PMC article.
-
A retrospective study: the prevalence and prognostic value of anemia in patients undergoing radiotherapy for esophageal squamous cell carcinoma.World J Surg Oncol. 2014 Aug 1;12:244. doi: 10.1186/1477-7819-12-244. World J Surg Oncol. 2014. PMID: 25085112 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical